相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Multicentre study of ceftazidime/avibactam for Gram-negative bacteria infections in critically ill patients
Barbara Balandin et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2022)
In vivo selection of KPC-94 and KPC-95 in Klebsiella pneumoniae isolates from patients treated with ceftazidime/avibactam
J. Guzman-Puche et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2022)
Assessment of Ceftazidime-Avibactam 30/20-μg Disk, Etest versus Broth Microdilution Results When Tested against Enterobacterales Clinical Isolates
Renru Han et al.
MICROBIOLOGY SPECTRUM (2022)
Emergence of a KPC-90 Variant that Confers Resistance to Ceftazidime-Avibactam in an ST463 Carbapenem-Resistant Pseudomonas aeruginosa Strain
Yuexing Tu et al.
Microbiology Spectrum (2022)
Real-Time Optimization of Pharmacodynamic Target Attainment at Infection Site during Treatment of Post-Neurosurgical Ventriculitis Caused by Carbapenem-Resistant Gram Negatives with Ceftazidime-Avibactam-Based Regimens: A Report of Two Cases
Milo Gatti et al.
MICROORGANISMS (2022)
Susceptibility of Meropenem-Resistant and/or Carbapenemase-Producing Clinical Isolates of Enterobacterales (Enterobacteriaceae) and Pseudomonas aeruginosa to Ceftazidime-Avibactam and Ceftolozane-Tazobactam as Assessed by In Vitro Testing Methods
Venere Cortazzo et al.
ANTIBIOTICS-BASEL (2022)
Comparative Evaluation of Vitek 2 and Etest versus Broth Microdilution for Ceftazidime/Avibactam and Ceftolozane/Tazobactam Susceptibility Testing of Enterobacterales and Pseudomonas aeruginosa
Arhodoula Papadomanolaki et al.
ANTIBIOTICS-BASEL (2022)
KPC-39-Mediated Resistance to Ceftazidime-Avibactam in a Klebsiella pneumoniae ST307 Clinical Isolate
Agnes B. Jousset et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Multicenter Evaluation of Ceftazidime-Avibactam Susceptibility Testing of Enterobacterales and Pseudomonas aeruginosa on the Vitek 2 System
Romney Humphries et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2021)
The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update
Dan Reynolds et al.
DRUGS (2021)
Molecular Mechanisms Driving the In Vivo Development of KPC-71-Mediated Resistance to Ceftazidime-Avibactam during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections
Xi Li et al.
MSPHERE (2021)
Performance of disc diffusion, MIC gradient tests and Vitek 2 for ceftolozane/tazobactam and ceftazidime/avibactam susceptibility testing of Pseudomonas aeruginosa
Brice Daragon et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)
Performance Evaluation of the Gradient Diffusion Strip Method and Disk Diffusion Method for Ceftazidime-Avibactam Against Enterobacterales and Pseudomonas aeruginosa: A Dual-Center Study
Jingjia Zhang et al.
FRONTIERS IN MICROBIOLOGY (2021)
In Vitro Activity of Cefepime-Zidebactam, Ceftazidime-Avibactam, and Other Comparators against Clinical Isolates of Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii: Results from China Antimicrobial Surveillance Network (CHINET) in 2018
Yang Yang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections
Johann Motsch et al.
CLINICAL INFECTIOUS DISEASES (2020)
Antimicrobial Resistance in ESKAPE Pathogens
David M. P. De Oliveira et al.
CLINICAL MICROBIOLOGY REVIEWS (2020)
Critical analysis of antibacterial agents in clinical development
Ursula Theuretzbacher et al.
NATURE REVIEWS MICROBIOLOGY (2020)
Evaluation of the Etest and disk diffusion method for detection of the activity of ceftazidime-avibactam against Enterobacterales and Pseudomonas aeruginosa in China
Qi Wang et al.
BMC MICROBIOLOGY (2020)
New beta-Lactam-beta-Lactamase Inhibitor Combinations
Dafna Yahav et al.
CLINICAL MICROBIOLOGY REVIEWS (2020)
Comparison of methods to analyse susceptibility of German MDR/XDR Pseudomonas aeruginosa to ceftazidime/avibactam
Frieder Schaumburg et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
Performance of ceftazidime/avibactam susceptibility testing methods against clinically relevant Gram-negative organisms
E. Wenzler et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Verification of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Susceptibility Testing Methods against Carbapenem-Resistant Enterobacteriaceae and Pseudomonas aeruginosa
Ryan K. Shields et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2018)
Ceftazidime-Avibactam: A Review in the Treatment of Serious Gram-Negative Bacterial Infections
Matt Shirley
DRUGS (2018)
Assessment of 30/20-Microgram Disk Content versus MIC Results for Ceftazidime-Avibactam Tested against Enterobacteriaceae and Pseudomonas aeruginosa
Helio S. Sader et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2018)
Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae
David van Duin et al.
CLINICAL INFECTIOUS DISEASES (2018)
Multiplex PCR for detection of acquired carbapenemase genes
Laurent Poirel et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2011)